GPC3 Targeted CAR-T Cell Therapy in Advanced GPC3 Expressing Solid Tumor Malignancies

NCT05003895 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

38

Enrollment

NIH

Sponsor class

Conditions

Hepatocellular Carcinoma
Hepatocellular Cancer
Metastatic Hepatocellular Carcinoma

Interventions

DRUG: Cyclophosphamide
BIOLOGICAL: CAR-T cell
DRUG: Fludarabine

Sponsor

National Cancer Institute (NCI)